INCELL Inside
  • Product Line
  • Reg Med
    • Cell & Tissue Products
      • Regenerative & Stem Cells
      • Tissue-Derived Products
      • Reagents & Testing
      • INCELL Established Cell Lines
    • Tissue Collections & Kit Products
    • Storage of Cell & Tissue Products
    • Services: Manufacturing , Testing and R&D
      • Accelerated Product Development Services
      • Regenerative & Stem Cell Products
  • Micro
    • Microbiology & Vaccine Products
      • Microbiology Testing
        • Sterility: GMP and USP Compliant
        • Microbial Bioburden
        • Endotoxin/Pyrogen Testing
        • Mycoplasma Testing
        • Antimicrobial & Microbiological Testing
    • Vaccines and Microbiology Products
      • Microbiology & Vaccines Collaborations
    • Clinical Studies
  • Clinical
    • Clinical Trials
    • Personalized Medicine
  • About
    • Corporate
      • Contact
      • History
      • Mission
      • Registration, Licenses & Certificates
      • Memberships, Boards and Committees
    • Organization & Management
      • Board Members
        • Executive Managers
      • Key Alliances
        • Collaborative Business Model
    • Business Units & Activities
      • Regenerative Medicine
      • Media, Solutions & Kits
      • Microbiology & Vaccine Products
  • FAQ
  • News
    • Blog
    • Social Media
    • News & Newsworthy
      • Press Releases
      • Announcements
      • Community & Service Activities
        • Current Boards & Outreach
        • Archives
      • White Papers & Publications
        • White Papers
        • Publications & Links
      • Presentations
        • Recent
        • Archives
  • Jobs

Recent Posts

  • Letter from INCELL’s CEO
  • Dr. Mary Pat Moyer inducted to the National Academy of Engineering for her contribution to regenerative medicine, October 2019
INCELL is a products manufacturer and contract services provider with the mission to provide "Innovative Life Science Solutions™" in biomedicine.

History

Mary Pat Moyer, PhD founded INCELL Corporation LLC as a women-owned San Antonio, Texas company in 1993. INCELL was built on a strong foundation of basic and clinical academic research, government grants and industry contracts with Dr. Moyer’s expertise in human cell biotechnology, formulation, regenerative medicine and microbiology. Since its inception, INCELL has been a manufacturer of sterile media and cell culture products and has provided contract and consulting services related to new product development and testing. The pyramid figure shows the evolution of the company’s capabilities and its GMP capabilities in manufacturing cell & tissue products, biologicals, and compounded drugs. The current emphasis is to bring INCELL’s and its clients’ products to the clinic. This will be assisted through an affiliated company 4RMED LLC and with new partnerships and collaborations.

INCELL: Company History

Product Categories

  • Collection, Transport and Processing Solutions
  • Compounded Drugs
  • Cryopreservation Media
    • EZ-CPZ ™ Cryopreservation Media Family
  • Culture Media
    • M3™ Media Family
  • Place Order
  • Proprietary Cell Lines
  • Sample Category
  • Services
  • Special Order
  • Tissue Collection Kits
  • Uncategorized

Recent Posts

  • Letter from INCELL’s CEO
  • Dr. Mary Pat Moyer inducted to the National Academy of Engineering for her contribution to regenerative medicine, October 2019
  • Dr. Moyer Addresses Orthopedic Physicians at AAOM National Meeting
  • INCELL Global Expansion
  • INCELL Sponsors WSCS in December 2016

Contact INCELL Corporation LLC

12734 Cimarron Path (Directions)
San Antonio, Texas 78249
Tel: 210-877-0100|Toll-free: 800.364.1765
Fax: 210-877-0200

Search Downloads

Privacy Policy | Sitemap | Contact

Copyright © 1993 - 2023. All Rights Reserved.

Designed by WebAuthorings.